| Q41904813 | A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease |
| Q35079575 | A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions |
| Q57098797 | Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease |
| Q36174042 | Actin reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal epithelial cells |
| Q46097846 | Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease |
| Q36155351 | Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period |
| Q34627198 | Adherent-invasive E. coli in Crohn disease: bacterial "agent provocateur" |
| Q38194867 | Advances in IBD genetics |
| Q61865732 | Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis |
| Q47343886 | Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility |
| Q38928108 | Alterations in microRNA expression profiles in inflamed and non-inflamed ascending colon mucosae of patients with active Crohn';s disease |
| Q94464395 | An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease |
| Q38040831 | Antimicrobial peptides and colitis |
| Q34987870 | Antimicrobial peptides and gut microbiota in homeostasis and pathology. |
| Q41477282 | Antimicrobial peptides in gastrointestinal inflammation |
| Q27023239 | Antimicrobial proteins in intestine and inflammatory bowel diseases |
| Q37845328 | Are NOD2 polymorphisms linked to a specific disease endophenotype of Crohn's disease? |
| Q34185576 | Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease |
| Q41882233 | Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection |
| Q38065286 | Autophagy and intestinal homeostasis |
| Q34024046 | Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn’s disease |
| Q28740558 | CEACAM6 gene variants in inflammatory bowel disease |
| Q42589189 | Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". |
| Q35190723 | Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease. |
| Q34391698 | Characteristic changes in microbial community composition and expression of innate immune genes in acute appendicitis. |
| Q43849278 | Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. |
| Q37878446 | Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. |
| Q50054942 | Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction. |
| Q64110872 | Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases |
| Q41441733 | Controversy over NOD2, inflammation, and defensins |
| Q35122791 | Critical design aspects involved in the study of Paneth cells and the intestinal microbiota |
| Q34132601 | Crohn disease: a current perspective on genetics, autophagy and immunity |
| Q37276947 | Crohn's disease--defect in innate defence. |
| Q35825462 | Crohn's disease-derived monocytes fail to induce Paneth cell defensins |
| Q38177269 | Debug Your Bugs - How NLRs Shape Intestinal Host-Microbe Interactions |
| Q35969912 | Decreased Pregnane X Receptor Expression in Children with Active Crohn's Disease |
| Q34212591 | Deregulated inflammasome signaling in disease |
| Q41422696 | Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals. |
| Q47963300 | Differential effects of Staphylococcal enterotoxin B-mediated immune activation on intestinal defensins. |
| Q97521540 | Does an Apple a Day Also Keep the Microbes Away? The Interplay Between Diet, Microbiota, and Host Defense Peptides at the Intestinal Mucosal Barrier |
| Q51829378 | Donkey milk consumption exerts anti-inflammatory properties by normalizing antimicrobial peptides levels in Paneth's cells in a model of ileitis in mice. |
| Q40365738 | Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. |
| Q37719188 | ER stress and the unfolded protein response in intestinal inflammation. |
| Q53290904 | Early modulation of gene expression used as a biomarker for chemoprevention in a preclinical model of colon carcinogenesis. |
| Q37351981 | Esophageal human β-defensin expression in eosinophilic esophagitis. |
| Q24623064 | Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates |
| Q57100645 | Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease |
| Q37930993 | From intestinal stem cells to inflammatory bowel diseases |
| Q24647448 | Function of Nod-like receptors in microbial recognition and host defense |
| Q33755171 | Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease. |
| Q28294695 | Gut microbiota and IBD |
| Q24631660 | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) |
| Q34058861 | Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli. |
| Q34311665 | Host genes related to paneth cells and xenobiotic metabolism are associated with shifts in human ileum-associated microbial composition |
| Q37302559 | Host-bacteria interaction in inflammatory bowel disease |
| Q37675501 | How the noninflammasome NLRs function in the innate immune system |
| Q34628470 | Immunopathogenesis of inflammatory bowel disease |
| Q37798821 | Impact ofClostridium difficileon inflammatory bowel disease |
| Q34093119 | Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum |
| Q39237282 | Inflammasomes and intestinal inflammation |
| Q29615500 | Inflammatory bowel disease |
| Q29616286 | Inflammatory bowel disease |
| Q34312402 | Inflammatory bowel disease: an impaired barrier disease |
| Q34311640 | Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition |
| Q33554402 | Interactions between the host innate immune system and microbes in inflammatory bowel disease |
| Q57119838 | Intestinal alpha-defensin expression in pediatric inflammatory bowel disease |
| Q38054086 | Intestinal antimicrobial peptides during homeostasis, infection, and disease |
| Q38293757 | Intestinal barrier homeostasis in inflammatory bowel disease. |
| Q39388017 | Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier. |
| Q34007118 | Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease. |
| Q37925059 | Intracellular sensors of extracellular bacteria |
| Q44531487 | KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population |
| Q40628192 | Lack of intestinal epithelial atg7 affects paneth cell granule formation but does not compromise immune homeostasis in the gut. |
| Q90633681 | Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses |
| Q33956751 | MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function |
| Q39141466 | Methanolic extract of white asparagus shoots activates TRAIL apoptotic death pathway in human cancer cells and inhibits colon carcinogenesis in a preclinical model |
| Q33765449 | Microbes, the gut and ankylosing spondylitis |
| Q36273576 | Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease |
| Q37351171 | Mouse Paneth cell antimicrobial function is independent of Nod2. |
| Q30945619 | Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment |
| Q30497993 | NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis |
| Q38171221 | NOD proteins: regulators of inflammation in health and disease |
| Q34745603 | NOD1 and NOD2: signaling, host defense, and inflammatory disease |
| Q46269946 | NOD2 and bacterial recognition as therapeutic targets for Crohn's disease. |
| Q55000637 | NOD2 and inflammation: current insights. |
| Q37727940 | NOD2 status and human ileal gene expression. |
| Q37172148 | NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease |
| Q42206092 | New treatment options in the management of IBD - focus on colony stimulating factors. |
| Q39203747 | Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance |
| Q37886430 | Nod-like receptors in intestinal homeostasis, inflammation, and cancer |
| Q37354181 | Nod2 is required for the regulation of commensal microbiota in the intestine |
| Q28079236 | Nod2: A Critical Regulator of Ileal Microbiota and Crohn's Disease |
| Q34210133 | Nod2: a key regulator linking microbiota to intestinal mucosal immunity |
| Q57124250 | Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation |
| Q50005480 | Paneth and intestinal stem cells preserve their functional integrity during worsening of acute cellular rejection in small bowel transplantation |
| Q26747303 | Paneth cell α-defensins and enteric microbiota in health and disease |
| Q54374775 | Paneth's disease. |
| Q38551892 | Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease. |
| Q35659341 | Pathogenesis of Crohn's disease |
| Q37087891 | Pro-inflammatory and pro-apoptotic properties of Human Defensin 5. |
| Q57156865 | Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification |
| Q34996068 | Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes |
| Q36685310 | Regulation of intestinal microbiota by the NLR protein family |
| Q34407175 | Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? |
| Q57154682 | Smoking behaviour modifiesIL23r-associated disease risk in patients with Crohn's disease |
| Q54357723 | Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease. |
| Q37419561 | The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene |
| Q37633135 | The Interplay between Defensins and Microbiota in Crohn's Disease |
| Q30994539 | The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants |
| Q34762033 | The Nlrp3 inflammasome: contributions to intestinal homeostasis |
| Q39444977 | The Risk of Inflammatory Bowel Disease Flares after Fecal Microbiota Transplantation: Systematic Review and Meta-Analysis. |
| Q37171800 | The genetics and immunopathogenesis of inflammatory bowel disease |
| Q37947675 | The role of human defensins in gastrointestinal diseases |
| Q38115440 | The role of the immune system in governing host-microbe interactions in the intestine |
| Q42636973 | Transcription factor TFEB cell-autonomously modulates susceptibility to intestinal epithelial cell injury in vivo |
| Q38972852 | Understanding the regulation of pattern recognition receptors in inflammatory diseases - a 'Nod' in the right direction |
| Q37502679 | Unleashing the therapeutic potential of NOD-like receptors |
| Q34611580 | Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis |